Bill Gates outlined a five-year plan to utilize mRNA technology for a wide range of diseases, including HIV, malaria, and tuberculosis, citing its low cost and scalability. The Bill and Melinda Gates Foundation recently partnered with the Novo Nordisk Foundation to focus on climate-related diseases and vaccine manufacturing. Discussion continues regarding the legal immunity granted to pharmaceutical companies for products labeled as vaccines versus gene therapies.

















